Robakis NK

References (2)

Title : Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit - Hoilund-Carlsen_2024_Ageing.Res.Rev__102348
Author(s) : Hoilund-Carlsen PF , Alavi A , Barrio JR , Castellani RJ , Costa T , Herrup K , Kepp KP , Neve RL , Perry G , Revheim ME , Robakis NK , Sensi SL , Vissel B
Ref : Ageing Res Rev , :102348 , 2024
Abstract :
PubMedSearch : Hoilund-Carlsen_2024_Ageing.Res.Rev__102348
PubMedID: 38830549

Title : The presenilin-1 familial Alzheimer's disease mutation P117L decreases neuronal differentiation of embryonic murine neural progenitor cells - Eder-Colli_2009_Brain.Res.Bull_80_296
Author(s) : Eder-Colli L , Abad-Estarlich N , Pannetier C , Vallet PG , Walzer C , Elder GA , Robakis NK , Bouras C , Savioz A
Ref : Brain Research Bulletin , 80 :296 , 2009
Abstract :
PubMedSearch : Eder-Colli_2009_Brain.Res.Bull_80_296
PubMedID: 19555743